Normal endometrial growth is essential for embryonic implantation and maintenance of pregnancy. The uterine endometrium contains stem cells that are involved in tissue regeneration. Side population cells (SP cells) are an emerging cell population that may be responsible for the regeneration process of uterine endometrium. In this study, we investigated the changes in the distribution of SP cells using a mouse model of uterine endometrial injury that was induced by peritoneal injection of lipopolysaccharide (LPS). The uterine horns were collected 0, 6, 12, and 18 hours after LPS injection. ATP-binding cassette and sub-family G member 2 (Abcg2) is highly expressed on the cellular membrane of some stem and progenitor cells, and was used as a marker for SP cells. Immunohistochemistry demonstrated that Abcg2-positive cells were increased around the uterine endometrial glands from 6 to 12 h after LPS injection. The percentage of Abcg2-positive cells was calculated using flow cytometry. The percentage of stromal SP cells was significantly higher at 6 h after LPS injection, compared with the value before the injection (3.01 ± 0.41% vs. 1.63 ± 0.31%, P < 0.05). To evaluate the influence of ovarian hormones, we implanted pellets containing 17β-estradiol (0.1 mg), progesterone (10 mg), or a combination of 17β-estradiol and progesterone in the bilaterally ovariectomized mice. Ovariectomy abolished the increase in SP cells, which was restored by estradiol, but not by progesterone or the combination treatment. In conclusion, estrogen is required for the increase of SP cells, thereby leading to the regeneration of the uterine endometrium.
Pregnancy requires effective cooperation between a receptive uterus and a superior blastocyst. Appropriate cyclic endometrial stromal and epithelial cell proliferation is critical for a receptive uterus, and an endometrial disorder can lead to infertility, pregnancy complications, miscarriage, endometriosis, and cancer (Gargett 2004 (Gargett , 2006 Chen et al. 2010 ). In the human uterine endometrium, glandular structures are supported by an extensive stroma that undergoes cyclical changes in growth, differentiation, and regression during each menstrual cycle; the endometrium is completely renewed in each menstrual cycle with a remarkable regenerative capacity (Gargett 2004) .
Stem/progenitor cells are known to be involved in tissue regeneration (Ferrari et al. 1998; Bjerknes and Cheng 1999; Gussoni et al. 1999; Alison et al. 2000; Jackson et al. 2001; Alonso and Fuchs 2003) . Recent studies have shown that stem/progenitor cells contribute to regeneration of endothelial cells (Jackson et al. 2001) , cardiomyocytes (Ferrari et al. 1998; Jackson et al. 2001) , and hepatocytes (Alison et al. 2000) . In addition, Chan et al. (2004) discovered endometrial cell subpopulations that act as endometrial progenitor/stem cells. Side population cells (SP cells) were originally discovered as a component of hematopoietic stem cells (Goodell et al. 1996) , and were recently identified by fluorescence-activated cell sorting (FACS) analysis as a cluster of stem and progenitor cells in adult tissues (Kato et al. 2007 ). Human endometrial SP cells might include putative progenitor/stem cells (Hugh and Taylor 2004; Kato et al. 2007; Masuda et al. 2010) that are mainly present in the vascular endothelium and the epithelium of the basal layer of the endometrium (Tsuji et al. 2008) . The aim of the current study was to explore the association between uterine endometrial regeneration and endometrial SP cells using a mouse model of uterine endometrial regeneration.
Materials and Methods

Uterine endometrial regeneration mouse model
Lipopolysaccharide (LPS) was obtained from Salmonella typhimurium (Sigma-Aldrich, St. Louis, MO). An equal volume of LPS (0.5 µg per g body weight) or phosphate-buffered saline (PBS) was injected peritoneally into a BALB/c mouse (8-16 weeks old, CLEA Japan, Tokyo, Japan) to cause uterine endometrium injury (Fischetti et al. 2004) . LPS-injected mice were used as a model of uterine endometrial regeneration, and PBS-injected mice served as controls. Mice were sacrificed by cervical dislocation at 6, 12, 18, 24 h, or one week and uterine horns collected. Specimens were used for histological examination and to analyze the distribution of SP cells in the uterine endometrium. This project was approved by the Institutional Animal Review Committee at Ehime University.
Abcg2-positive cell distribution in the injured uterine endometrium
Uterine horns derived from LPS-treated and control mice were fixed in formaldehyde and embedded in paraffin. Some strip preparations were stained with hematoxylin and eosin (H&E), and others were used for immunohistochemical detection of the ATP-binding cassette and sub-family G member 2 (Abcg2) protein (Zhou et al. 2001; Shimano et al. 2003) . Samples were incubated with a peroxidase block solution to quench endogenous peroxidase, followed by a protein blocking agent for five min at room temperature (RT). Samples were incubated with diluted rabbit anti-mouse Abcg2 polyclonal antibody (Kamiya Biomedical Company, Seattle, WA) overnight at 4°C and washed with PBS containing 0.1% Tween-20, followed by sequential 20 min incubations at RT with DAKO LSAB+ biotinylated anti-rabbit secondary antibody (LSAB2 kit, DAKO Corporation, Glostrup, Denmark). Samples were washed and incubated with streptavidin-horseradish peroxidase conjugate for 20 min at RT, washed again, and incubated with AEC substrate chromogen for three min at RT. After washing, specimens were counterstained with Mayer's hematoxylin (Sakura Finetek Japan, Tokyo, Japan) for 10 sec. Control sections were prepared using anti-mouse IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA). To evaluate the endometrial injury in semi-quantitative manner, we counted the number of necrotic cells among 100 endometrial cells in the microscope field (× 400). The necrotic cell was defined as a cell that is vacuolated with nuclear debri. We used three uterine horns and investigated five fields in each horn and calculated the average (n = 15). The data are demonstrated as percentage.
Preparation of uterine endometrial epithelial and stromal cell suspensions
Endometrial epithelial cell preparation was as described previously (Satyaswaroop et al. 1979) . In brief, endometrial tissue was removed from uterine horns using a rubber scraper. The tissue was washed thoroughly with PBS to remove blood, minced finely with scalpels, and placed in RPMI 1640 containing 0.25% collagenase (Sigma-Aldrich). The suspension was incubated for 60 min at 37°C in a water bath, and DMEM/F12 containing 10% fetal calf serum (FCS, Invitrogen Corporation, Carlsbad, CA) was added. After two PBS washes, suspensions were filtered using a 250 µm stainless steel mesh to separate epithelial and stromal cell fractions. The epithelial cell fraction was washed twice with PBS and resuspended in RPMI 1640 containing 0.25% trypsin-1mM EDTA (Invitrogen Corporation). This suspension was incubated for 30 min at 37°C in a water bath with shaking and DMEM/F12 containing 10% FCS was added. After two PBS washes, the suspension was filtered using a 50 µm nylon mesh. Cells were mixed with 0.84% w/v ammonium chloride (pH 7.5) and incubated at RT for 5 min to eliminate all erythrocytes.
The stromal cell fraction was filtered using a 50-µm nylon mesh. Cells were mixed with 0.84% w/v ammonium chloride (pH 7.5) and incubated at RT for 5 min to eliminate all erythrocytes.
Measurement of SP cell percentage in the injured uterine endometrium
Cell suspensions were incubated with Hoechst 33342 (5 µg/1 × 10 6 cells, Invitrogen Corporation) for 60 min at 37°C in a water bath with shaking, followed by a wash with Hank's buffered salt solution (HBSS) containing 2% FCS. Cell viability was assessed by propidium iodide (PI) staining (2 µg/mL). The cell suspension was adjusted to 1 × 10 6 cells per mL of RPMI 1640. Contamination was determined using FACS and cultivation, and the data from contaminated fractions was eliminated. Cells were analyzed in the presence or absence of 100 µM verapamil (Montanaro et al. 2004 ). FACS analysis was performed using a dual laser FACS Vantage SE (Becton Dickinson, Franklin Lakes, NJ) with the following settings: lasers, 488 nm argon ion laser (Innova C, Coherent Inc., Santa Clara, CA) and multiline high UV output 365 nm laser (Innova 90-6, Coherent Inc.); laser power, 200 mW for the 488 nm laser, 150 mW for the 365 nm laser; filters for PI, which has two excitation peaks and could be excited with both lasers, excitation from the 365 nm laser for visualizing SP cells. Emission signals from Hoechst and PI were first separated using a 500 SP dichroic mirror, and detected using 400 LP and 600 LP filters, respectively. PI signal was elicited by excitation in the visible range. The SP cell fraction was identified using forward scatter, side scatter, Hoechst blue (450 nm), and Hoechst red (675 nm). Clusters of weakly luminescent cells by Hoechst blue and red included SP cells. This characteristic of SP cells is due to the ability of the primitive cells to pump out the DNA binding dye Hoechst 33342 via Abcg2 (Challen and Little 2006) , and this activity is inhibited by verapamil (Fig. 1) . The percentage of SP cells in the endometrium was determined at 0 (LPS: n = 5, PBS: n = 7), 6 (LPS: n = 12, PBS: n = 5), 12 (LPS: n = 9, PBS: n = 6), and 18 (LPS: n = 9, PBS: n = 7) h after LPS injection.
Ovarian hormone effect on SP cell distribution in the injured uterine endometrium
To evaluate the effect of ovarian hormones on the distribution of SP cells in the injured uterine endometrium, mice were anesthetized intraperitoneally with pentobarbital and bilateral surgical ovariectomy was performed. Pellets containing vehicle (placebo), 17β-estradiol (0.1 mg/pellet), progesterone (10 mg), or a combination of 17β-estradiol and progesterone were implanted subcutaneously in the ovariectomized mice. The pellets (21-day timed-release) were obtained from Innovative Research of America (Sarasota, FL) and were designed for the constant release of placebo or physiological amounts of sex steroid (Xu et al. 2006; Suzuki et al. 2008 ). An incision was made in the backside of the mouse, followed by bilateral removal of the ovaries. Hormone pellets were placed subcutaneously under the backside of the neck. The LPS solution was injected peritoneally two weeks later. Uterine horns were collected 0, 6, 12, and 18 h after LPS injection and the uterine endometrial cells were prepared. Flow cytometry using Hoechst 33342 was used to determine the percentage of SP cells, which was counted in the endometrium at 0 (placebo: n = 4, estradiol: n = 4, progesterone: n = 5, estradiol and progesterone: n = 5), 6 (placebo: n = 3, estradiol: n = 4, progesterone: n = 4, estradiol and progesterone: n = 5), 12 (placebo: n = 4, estradiol: n = 3, progesterone: n = 5, estradiol and progesterone: n = 3), and 18 (placebo: n = 6, estradiol: n = 6, progesterone: n = 4, estradiol and progesterone: n = 6) h after LPS injection. The plasma concentration of estradiol and progesterone 2 weeks after ovariectomy was measured by chemiluminescent immunoassay using an immunoassay analyzer (Architect i2000; Abbott Laboratories, Abbott Park, IL).
Statistical analysis
Results are expressed as means ± standard error of the meant (SEM). Statistical analyses were performed by one-way analysis of variance followed by a post-hoc test (Bonferroni). Statistical significance was determined as P < 0.05.
Results
Uterine endometrial regeneration in mice
Uterine endometrial injury was observed at 6-12 h after LPS injection ( Fig. 2A b, c, g, h) . Vacuolation with nuclear debri (arrows), which was caused by cellular necrosis, was detected at the border between the uterine endometrial epithelium and stroma 6 h after LPS injection. A few granulocytes were aggregated around the epithelium and in the uterine muscular layer; however, the inflammatory reaction was not significant. Repair of the endometrial injury was evident by 24 h after LPS injection ( Fig. 2A d, i) , and the injury was completely repaired by one week after LPS injection ( Fig. 2A e, j) . Although mice do not have a menstrual cycle, they were suitable as a model for endometrial regeneration experiments because they can undergo a process of uterine endometrial injury and regeneration. Necrotic cells were significantly increased 12 h after LPS injection (43.87 ± 18.90% vs. 16.8 ± 13.82% before the injection; P < 0.001, Fig. 2B ). The percentage returned to the level before the injection on 7 days after the injection (12.00 ± 9.35%).
The distribution of Abcg2-positive cells in the injured uterine endometrium
Immunohistochemistry with anti-Abcg2 antibody demonstrated that a few Abcg2-positive cells (arrows), which are related to SP cells, resided in the uterine endometrial stroma even before LPS injection (Fig. 3a) , and these increased around the uterine endometrial glands and vessels from 6 to 12 h after LPS injection (Fig. 3b, c) . Abcg2-positive cells decreased at 18 h after LPS injection (Fig. 3  d) . However, Abcg2-positive cells could not be found in the uterine endometrial epithelium before LPS injection (Fig. 3a) , and a few cells were found beneath the epithelium at 12 h after LPS injection ( Fig. 3c; inset) . No immunoreactivity was observed with control IgG (Fig. 3e, f, g, h) . This figure demonstrated for the first time that the Abcg2-positive cells accumulated in a short time during uterine endometrial regeneration. Injured uterine endometrium was quickly repaired and SP cells might be involved in the regeneration because Abcg2-positive cells were increased at the uterine endometrial injury.
Percentage of SP cells in the injured uterine endometrium
The percentage of SP cells increased significantly in the endometrial stroma by 6 h after LPS injection (3.01 ± 0.41% vs. 1.63 ± 0.31% before the injection; P < 0.05) (Fig.  4A ). In the endometrial epithelium, the percentage of cells increased more gradually after LPS injection, peaking at 6 h after injection (2.61 ± 0.19% vs. 1.52 ± 0.37% at 0 h; P < 0.005) (Fig. 4B ). Shortly after LPS injection, SP cells increased in the uterine endometrium. The plasma concentration of estradiol and progesterone at 2 weeks after ovariectomy is shown in Table 1 . Analysis of ovariectomized mice demonstrated no change in the percentage of SP cells in the endometrial stroma and epithelium after LPS injection (data not shown). Estradiol treatment of ovariectomized mice led to an increase in SP cell population (19.43 ± 1.95%) before LPS injection and LPS injection led to an increase in stromal SP cell population in estradiol-treated ovariectomized mice at 6 h after LPS injection (23.80 ± 2.26%). In contrast, progesterone . 17β estradiol increased the percentage of SP cells in the endometrial stroma at 6 h after LPS injection in ovariectomized mice (closed circles). Progesterone had no effect on SP cell percentage in ovariectomized mice (open squares); however, progesterone significantly reduced the 17β estradiol-induced increase in SP cell percentage (closed squares). B) The percentage of SP cells also did not change in the uterine endometrial epithelium after LPS injection in placebo-treated ovariectomized mice (open circles). 17β estradiol significantly increased the percentage of SP cells in the endometrial epithelium at six hours after LPS injection (closed circles). Progesterone had no effect on SP cell percentage in ovariectomized mice (open squares); however, progesterone significantly reduced the 17β estradiolinduced increase in SP cell percentage (closed squares). Values are mean ± SEM. *P < 0.05 vs. progesterone treatment or placebo. **P < 0.05 vs. estradiol and progesterone treatment, progesterone treatment, or placebo. ***P < 0.005 vs. estradiol and progesterone treatment, progesterone treatment, or placebo. † P < 0.05 vs. 0 h. treatment did not influence SP cell percentage in ovariectomized mice; instead, it reduced the estradiol effect in ovariectomized mice before injection (8.48 ± 1.77%, n = 5, Fig.  5A ) and a similar change was observed in the endometrial epithelium. LPS injection led to a significant increase in SP cell number in estradiol-treated ovariectomized mice at 6 h after LPS injection (17.77 ± 2.45%, P < 0.05 vs. 0 h). In contrast, progesterone treatment did not influence SP cell percentage in ovariectomized mice and rather reduced the estradiol effect in ovariectomized mice at 6 h after LPS injection (2.36 ± 0.44%, P < 0.005, Fig. 5B ). In conclusion, LPS injection did not increase the population of SP cells in ovariectomized mice; however, the degree of increase was restored by estradiol treatment but not by progesterone or the combination treatment.
Discussion
In this study, we demonstrated that SP cells rapidly accumulated in the murine uterine endometrium during experimental regeneration. We used endometrial SP cells to analyze progenitor/stem cells, since there are no specific progenitor/stem cell markers in the uterine endometrium. Murine endometrium consists of a single layer that contains epithelium and stroma (Martin et al. 1973) and is different from human endometrium (Padykula 1991; Okulicz et al. 1997) . However, a single epithelial progenitor or stem cell could serve as the origin of the murine uterine gland since the murine uterine endometrial gland is monoclonal, like the human endometrial gland (Gargett 2007) . Therefore, the murine endometrium is considered a suitable model of uterine endometrial regeneration.
A stem cell population is thought to be located in the lower region of the murine uterine endometrial stromal compartment (Cervelló et al. 2007) , which is consistent with our finding that SP cells remained primarily in the murine stromal layer. Furthermore, few progenitor/stem cells reside in the basalis layer near the human endometrial myometrial-junction (Okulicz et al. 1997; Heryanto and Rogers 2002; Chan et al. 2004 ) and the endometrium regenerates from the lower basalis layer (Chan et al. 2004) .
SP cells are also known to reside in skeletal muscle (Uezumi et al. 2006) . The number of muscle-derived SP cells increased during muscle regeneration after muscle injury, and the number of SP cells returned to a normal level at a late stage in muscle regeneration (Uezumi et al. 2006) . It is therefore conceivable that tissue injury could induce a temporary increase in the percentage of SP cells, and that SP cells might be involved in tissue repair.
The origin of endometrial progenitor/stem cells is not known. However, two possibilities have been proposed (Gargett 2007) . The first possibility is that the progenitor/ stem cells are derived from remnant fetal cells that continuously maintain the endometrium (Gargett 2007) . Pro genitor/stem cells might reside in the uterine endometrial stroma with or without injury and may differentiate into uterine endometrial stroma and epithelium (Hugh and Taylor 2004 ).
This result is compatible with our finding that very few cells were present even in the absence of injury, and injury increased SP cell in the uterine endometrium.
The second possibility is that bone marrow-derived progenitor/stem cells function during endometrial injury, including mense. Endometrial injury could stimulate not only progenitor/stem cell proliferation and release from the bone marrow into systemic circulation, but also migration to the uterine endometrium (Tibbetts et al. 1999; Hugh and Taylor 2004; Gargett 2007) . During the proliferative phase, CD34
+ hematopoietic stem cells are recruited from systemic circulation (Trundley and Moffett 2004) . In addition, Bratincsák et al. (2007) found that CD45 + bone marrowderived cells incorporated into the uterine epithelium and play an important role in endometrial regeneration. On the other hand, a bone marrow-derived stem cell disorder is known to be associated with infertility (Lynch et al. 2007) . Furthermore, recent studies have shown that bone marrowderived multipotent mononuclear cells are capable of differentiating into many different kinds of mature cells, including uterine endometrial cells (Fukada et al. 2002; LaBarge and Blau 2002) . The progenitor/stem cells, which are partly derived from the bone marrow, could be responsible for the rapid cyclical regeneration of the uterine endometrium during menstruation or injury . Both mechanisms have been postulated to act in concert to regulate uterine endometrial regeneration.
Estradiol played an important role in the SP cell increase 6 h after LPS injection, because in ovariectomized mice, estradiol restored the increase seen 6 hours after LPS injection. It is known that estrogen receptor-alpha is expressed in 16% of uterine endometrial stromal stem cells . Estrogen could be responsible for uterine endometrial regeneration by stimulating progenitor/stem cell proliferation (Razandi et al. 2003) .
On the other hand, progesterone inhibited estradiolinduced SP cell proliferation in ovariectomized mice. It is known that progesterone abolishes or alters the effect of estrogen on lipoproteins (Newnham 1993; Psaty et al. 1993 ) and reendothelialization after vascular injury (Levine et al. 1996) . It is thought that progesterone decreases estrogen receptor expression in the human uterine vascular endothelium (Perrot-Applanat et al. 1994; McDonnell et al. 1995) , thereby attenuating estrogen-induced angiogenic responses (Resnik et al. 1977; Magness et al. 1998) .
Further studies will be required to identify the specific endometrial progenitor/stem cell population; however, we concluded that SP cells in uterine endometrium could be involved in the endometrial regeneration and ovarian hormones could regulate the change.
